Davita Healthcare Partners Inc
(DVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 747,685 | 507,436 | 232,216 | 1,250,737 | 901,492 |
| Depreciation Amortization | 528,645 | 351,155 | 176,451 | 723,860 | 549,758 |
| Income taxes - deferred | 68,989 | -9,838 | 4,335 | -57,840 | -53,713 |
| Accounts receivable | -144,688 | -288,447 | -155,276 | -29,766 | -175,643 |
| Accounts payable and accrued liabilities | 97,879 | 35,612 | 46,195 | 1,699 | -43,414 |
| Other Working Capital | -208,411 | -461,753 | -290,151 | -29,821 | -91,157 |
| Other Operating Activity | 255,675 | 370,080 | 166,239 | 163,169 | 387,088 |
| Operating Cash Flow | $1,345,774 | $504,245 | $180,009 | $2,022,038 | $1,474,411 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 18,857 | -24,098 | -26,285 | 2,745 | -2,011 |
| PPE Investments | -398,097 | -241,949 | -132,584 | -555,443 | -366,849 |
| Net Acquisitions | -118,337 | -10,596 | -10,243 | -246,068 | -161,210 |
| Purchase Of Investment | -2,466 | 45,870 | N/A | -5,205 | -4,497 |
| Sale Of Investment | 6,706 | N/A | 5,662 | N/A | 4,558 |
| Purchase Sale Intangibles | N/A | N/A | N/A | 25,862 | N/A |
| Other Investing Activity | 1,514 | 1,470 | 1,312 | 32,542 | 6,554 |
| Investing Cash Flow | $-491,823 | $-229,303 | $-162,138 | $-771,429 | $-523,455 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,672,170 | 4,189,716 | 633,189 | 6,624,310 | 6,623,634 |
| Debt Repayment | -3,880,721 | -3,373,300 | -345,965 | -5,515,213 | -5,437,907 |
| Common Stock Issued | 17,583 | 8,913 | 4,937 | 20,453 | 15,204 |
| Common Stock Repurchased | -1,464,173 | -994,095 | -541,845 | -1,385,932 | -1,020,550 |
| Other Financing Activity | -305,118 | -209,328 | -132,856 | -560,555 | -432,215 |
| Financing Cash Flow | $-960,259 | $-378,094 | $-382,540 | $-816,937 | $-251,834 |
| Exchange Rate Effect | 21,897 | 20,286 | 9,417 | -18,481 | -5,112 |
| Beginning Cash Position | 879,825 | 879,825 | 879,825 | 464,634 | 464,634 |
| End Cash Position | 795,414 | 796,959 | 524,573 | 879,825 | 1,158,644 |
| Net Cash Flow | $-84,411 | $-82,866 | $-355,252 | $415,191 | $694,010 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,345,774 | 504,245 | 180,009 | 2,022,038 | 1,474,411 |
| Capital Expenditure | -430,434 | -264,349 | -143,258 | -555,443 | -384,786 |
| Free Cash Flow | 915,340 | 239,896 | 36,751 | 1,466,595 | 1,089,625 |